← SynDRA
SNX 5422
SynDRA canonical compound SYN0022893 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | HSP90AA1 | HSP90AB1 |
|---|
| Mechanism of action | HSP inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- HSP90AA1 INHIBITOR
- Heat shock protein HSP90 inhibitor
- HSP90AB1 INHIBITOR
- HSP inhibitor
Cross-references
Synonyms
- Snx-5422
- Pf-04929113
- Pf-4929113
- PF 04929113
- SNX5422
- UNII-BF52J69Q8T
- PF-04929113 (SNX-5422)
- BF52J69Q8T
- PF04929113
- PF-4929113
- cc-40
- MLS006011083
- SCHEMBL1220791
- SCHEMBL1220790
- CHEMBL1195136
- SCHEMBL15604989
- DTXSID50238270
- C25H30F3N5O4
- MolPort-023-293-502
- BCPP000065
- HMS3656B09
- EX-A2343
- BCP02427
- s2656
- ZINC95616595
- ABP000737
- ZINC100071931
- ZINC252517142
- AKOS027276395
- SB16643
- DB06070
- API0008143
- RL05706
- SNX-5422 /
- CS-0272
- NCGC00346640-01
- NCGC00386184-02
- Glycine, trans-4-((2-(aminocarbonyl)-5-(4,5,6,7-tetrah
- snx-5422
Look up SNX 5422 in the interactive SynDRA portal →